AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term survival when given as adjuvant therapy for early breast ...

Domestic pharma valuations are rich in the context of long-term risks, such as slower growth and regulatory interventions, ...

Indian pharmaceutical companies, which benefited from sector tailwinds such as stable generic pricing and shortage-led opportunities and stable costs of raw materials in the past 18-24 months, will ...

A U.S. appeals court ruled that Novartis can't prevent MSN Pharmaceuticals' proposed generic of heart drug Entresto.

Leerink initiated coverage of ANI Pharmaceuticals (ANIP) with an Outperform rating and $80 price target The firm believes the market is yet to ...

A group representing long-term care pharmacists asked Congress on Tuesday to rectify loopholes in Medicare drug price ...

Speaking at the Parliament on Tuesday, Dec 10, during Prime Minister’s Question Time, PM Anwar said generic medicines are ...

Sorbh Gupta, Senior Fund Manager at Bajaj Finserv AMC, expresses optimism about consumption trends and the pharmaceutical ...

Speaking at the Parliament on Tuesday, Dec 10, during Prime Minister’s Question Time, PM Anwar said generic medicines are more popular in Brazil, India, and China and it was not necessary for it to be ...

Save your organic dollars for foods more likely to harbor pesticide residues, like soft-skinned fruits, meat, milk and ...

StockNews.com lowered shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday. Separately, Barclays cut their ...

Steve Pickette, PharmD, BCPS, emphasizes that AI can streamline prescribing and formulary management for biosimilars and ...